SCHEMBL8017457

SCHEMBL8017457

CC(C)C[C@H](NC(=O)CNC(=O)CN)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
MAPT P10636 1/20 0.51
MEN1 O00255 1/20 0.50
LMNA P02545 1/20 0.50
KMT2A Q03164 1/20 0.50
LAP3 P28838 3/20 0.46
FOLH1 Q04609 4/20 0.45
GRN P28799 2/20 0.44
SORT1 Q99523 2/20 0.44
MME P08473 1/20 0.44
PSMB5 P28074 2/20 0.43
OPRM1 P35372 1/20 0.42
OPRD1 P41143 1/20 0.42
OPRK1 P41145 1/20 0.42
PLA2G2A P14555 2/20 0.41
PLA2G5 P39877 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19967700 1.00 ALDH1A1 (0.53) ALDH1A1MAPTMEN1LMNAKMT2A
SCHEMBL15757059 1.00 ALDH1A1 (0.53) ALDH1A1MAPTMEN1LMNAKMT2A
SCHEMBL30544338 0.94 ALDH1A1 (0.47) ALDH1A1MAPTMEN1LMNAKMT2A
SCHEMBL29883433 0.90 MME (0.47) ALDH1A1MAPTMEN1LMNAKMT2A
SCHEMBL30808873 0.90 ALDH1A1 (0.46) ALDH1A1MAPTMEN1LMNAKMT2A
SCHEMBL11127918 0.89 ALDH1A1 (0.49) ALDH1A1MAPTMEN1LMNAKMT2A
SCHEMBL3873046 0.88 ALDH1A1 (0.45) ALDH1A1MAPTMEN1LMNAKMT2A
SCHEMBL6517513 0.88 OPRM1 (0.45) ALDH1A1MAPTMEN1LMNAKMT2A
SCHEMBL65868 0.88 ALDH1A1 (0.62) ALDH1A1MAPTMEN1LMNAKMT2A
SCHEMBL29148902 0.88 ALDH1A1 (0.62) ALDH1A1MAPTMEN1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3686 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4680261-A1 PRODUCTS AND METHODS FOR TREATING METABOLIC, CARDIOVASCULAR, INFLAMMATORY AND ONCOLOGICAL DISEASES The Regents Of The University Of Michigan (US) 2026-01-21 EP claimed
US-20260001947-A1 MULTISPECIFIC ANTIBODY AND PREPARATION METHOD AND USE THEREOF MABNOOAH LLC (US) 2026-01-01 US claimed
US-12415852-B2 Multispecific antibody and preparation method and use thereof MABNOOAH LLC (US) 2025-09-16 US claimed
WO-2024192564-A1 PRODUCTS AND METHODS FOR TREATING METABOLIC, CARDIOVASCULAR, INFLAMMATORY AND ONCOLOGICAL DISEASES THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2024-09-26 WO claimed
US-12037415-B2 Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient YUYU PHARMA, INC. (KR) 2024-07-16 US claimed
WO-2024132726-A1 SERUM PEPTIDE PATTERNS FOR DIAGNOSTICS OF ACUTE ISCHEMIC STROKE IN HUMANS AND DIFFERENTIAL DIAGNOSIS OF ACUTE ISCHEMIC STROKE FROM INTRACRANIAL HEMORRHAGIC STROKE UNIWERSYTET GDANSKI (PL) 2024-06-27 WO claimed
CN-117843750-A Derived polypeptide based on Dermaseptin family, optimization method and application thereof 温州大学 2024-04-09 CN claimed
CN-117069793-A Bifunctional linker compound, antibody drug conjugate, and preparation methods and applications thereof 杭州爱科瑞思生物医药有限公司 2023-11-17 CN claimed
CN-116870187-A Antibody conjugated drugs of N-oxacycloalkyl-substituted camptothecin derivatives 杭州爱科瑞思生物医药有限公司 2023-10-13 CN claimed
CN-113416258-B Multispecific antibody and preparation method and application thereof 北京免疫方舟医药科技有限公司 2023-08-29 CN claimed
CN-110105450-B VEGF single domain antibody, nucleotide sequence and kit 深圳普瑞金生物药业股份有限公司 2023-07-04 CN claimed
US-20230181673-A1 TRI-PEPTIDES AND TREATMENT OF METABOLIC, CARDIOVASCULAR AND INFLAMMATORY DISORDERS DIAPIN THERAPEUTICS LLC 2023-06-15 US claimed
WO-2023003984-A2 LABEL-FREE DETECTION OF PROTEASE ACTIVITY OREGON HEALTH & SCIENCE UNIVERSITY (US) 2023-01-26 WO claimed
CN-110003329-B Polypeptide, IL17A/F single domain antibody, nucleotide sequence and kit 深圳普瑞金生物药业股份有限公司 2022-09-27 CN claimed
CN-106699839-B Process for synthesizing Diapin (Gly-Gly-leu) by chemical method 北京双鹭药业股份有限公司 2022-02-01 CN claimed
US-20150291659-A1 SOLOMONAMIDE ANALOGUE COMPOUNDS, PHARMACEUTICALS CONTAINING SOLOMONAMIDE ANALOGUE COMPOUNDS, AND PROCESSES FOR THE PREPARATION THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-10-15 US claimed
EP-2925771-A1 A PROCESS FOR THE PREPARATION OF SOLOMONAMIDE ANALOGUES Council of Scientific & Industrial Research (IN) 2015-10-07 EP claimed
WO-2014083578-A1 A PROCESS FOR THE PREPARATION OF SOLOMONAMIDE ANALOGUES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESERACH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) 2014-06-05 WO claimed
CN-117003803-B Crystal form of trisaccharide Hengrui (Qingdao) Biotechnology Co.,Ltd. (CN) 2026-05-26 CN disclosed
EP-0447547-A1 C-TERMINUS AMIDATION ENZYME COMPOSITION, PROCESS FOR ITS PREPARATION AND ITS USE SHISEIDO COMPANY LIMITED (JP) 1991-09-25 EP disclosed